M. Ray

发表

Relationship of platelet aggregation to bleeding after cardiopulmonary bypass.

M. Ray, G. Hawson, S. Just, 1994, The Annals of thoracic surgery.

Stability of the activated partial thromboplastin time used to monitor unfractionated heparin

M. Ray, 2008, Journal of thrombosis and haemostasis : JTH.

Pre‐operative platelet‐bound CD40 ligand is probably associated with peri‐operative cardiac events in hip and knee arthroplasty

M. Ray, D. Walters, R. Crawford, 2010, European journal of clinical investigation.

A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulation.

M. Ray, D. Walters, N. Bett, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty – a prospective randomized double‐blind placebo‐controlled study

M. Ray, R. Crawford, S. Whitehouse, 2005, Journal of thrombosis and haemostasis : JTH.

Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass.

M. Ray, K. Brown, M. O'brien, 1999, The Annals of thoracic surgery.

Investigation of factors relating to neuropsychological change following cardiac surgery

M. Ray, A. Hinton-Bayre, P. Raymond, 2007, Perfusion.

The Dependence of the International Sensitivity Index on the Coagulometer Used to Perform the Prothrombin Time

M. Ray, I. Smith, 1990, Thrombosis and Haemostasis.

Increased CD40 ligand expression on platelets is associated with cardiovascular events after total hip arthroplasty

M. Ray, M. Jabur, S. Crawford, 2006, Journal of thrombosis and haemostasis : JTH.

Erroneous D-dimer result on a paediatric citrated specimen.

M. Ray, P. Carroll, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Increased expression of monocyte tissue factor and soluble CD40 ligand at mid-term follow-up following percutaneous coronary intervention.

M. Ray, D. Walters, J. Layland, 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery.

M. Ray, A. Hinton-Bayre, P. Raymond, 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Heparin monitoring during cardiac surgery. Part 2: calculating the overestimation of heparin by the activated clotting time

Nancy E. Marsh, M. Ray, P. Raymond, 2003, Perfusion.

A low volume specimen container suitable for monitoring the aPTT of heparinized patients.

M. Ray, G. Hawson, S. Just, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

M. Ray, 1991, Thrombosis and Haemostasis.

Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.

M. Ray, E. G. Stafford, M. O'brien, 2001, The Annals of thoracic surgery.

Platelet and Leukocyte Activation in Salvaged Blood and the Effect of Its Reinfusion on the Circulating Blood

M. Ray, R. Crawford, S. Whitehouse, 2007, Clinical orthopaedics and related research.

Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.

M. Ray, N. Marsh, 1997, Thrombosis and haemostasis.

Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass.

M. Ray, G. Hawson, S. Just, 1997, The Annals of thoracic surgery.

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost.

M. Ray, M. O'brien, Michael J. Ray, 2001, The Annals of thoracic surgery.

Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.

M. Ray, N. Marsh, M. Hales, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time

M. Ray, P. Raymond, N. Marsh, 2003, Perfusion.

Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass

M. Ray, G. Hawson, N. Marsh, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A Brief Review of Studies Evaluating the Adverse Effects of Aprotinin Therapy in Aortocoronary Bypass Surgery

K. Mengerson, M. Ray, N. Marsh, 1997, Thrombosis and Haemostasis.

Naive Bayesian prediction of bleeding after heart by-pass surgery

I. Smith, Raymond Lister, M. J. Ray, 2001, The Seventh Australian and New Zealand Intelligent Information Systems Conference, 2001.

The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery

M. Ray, G. Hawson, E. Perrin, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

High‐dose tirofiban with enoxaparin and inflammatory markers in high‐risk percutaneous intervention

M. Ray, D. Walters, C. Aroney, 2010, European journal of clinical investigation.

Changes in plasminogen activator inhibitor-1 levels in non-small cell lung cancer.

M. Ray, G. Hawson, S. Pavey, 1996, Bollettino della Societa italiana di biologia sperimentale.

Aprotinin Reduces Blood Loss after Cardiopulmonary Bypass by Direct Inhibition of Plasmin

M. Ray, Neville Marsh, 1997, Thrombosis and Haemostasis.

Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab.

M. Ray, J. Cameron, D. Walters, 2005, International journal of cardiology.

Toluene Dose-Response and Preliminary Study of Proteomics for Neuronal Cell Lines

T. R. Sterner, M. Ray, D. Mattie, 2015 .

A comparison of two APTT reagents which use silica activators.

M. Ray, G. Hawson, 1989, Clinical and laboratory haematology.

Test–Retest Norms and Reliable Change Indices for the MicroCog Battery in a Healthy Community Population Over 50 Years of Age

M. Ray, A. Hinton-Bayre, P. Raymond, 2006, The Clinical neuropsychologist.

Aprotinin Reduces BIood Loss

M. Ray, Neville Marsh, 2018 .

Point‐of‐care testing shows clinically relevant variation in the degree of inhibition of platelets by standard‐dose abciximab therapy during percutaneous coronary intervention

M. Ray, D. Walters, C. Aroney, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A proposed model to monitor heparin therapy using the concentrated thrombin time which allows standardisation of reagents and improved estimation of heparin concentrations.

M. Ray, G. Hawson, E. Perrin, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

An attempt to standardize APTT reagents used to monitor heparin therapy

M. Ray, G. Hawson, P. Carroll, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.